Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.

Journal of Urology

Volumn 158, Issue 2, 1997, Pages 502-504

  Morote, J ^a   Raventos, C X ^a   Lorente, J A ^a   Lopez Pacios, M A ^a   Encabo, G ^a   De Torres, I ^a   Andreu, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0030854473     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199708000-00049     Document Type: Article

References (12)

1. Oesterling J.E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate J. Urol. 145 1991 907
2. Catalona W.J. Richie J.P. Ahmann F.R. Hudson M.A. Scardino P.T. Flanigan R.C. de Kernion J.B. Ratliff T.L. Kavoussi L.R. Dalkin B.L. Waters W.B. MacFarlane M.T. Southwick P.C. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol. 151 1994 1283
3. Benson M.C. Whang I.S. Pantuck A. Ring K. Kaplan S.A. Olsson C.A. Cooner W.H. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J. Urol. 147 1992 815
4. Benson M.C. Whang I.S. Olsson C.A. McMahon D.J. Cooner W.H. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol. 147 1992 817
5. Brawer M.K. Aramburu E.A.G. Chen G.L. Preston S.D. Ellis W.J. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen index the diagnosis of prostatic carcinoma. J. Urol. 150 1993 369
6. Catalona W.J. Hudson M.A. Scardino P.T. Richie J.P. Ahmann F.R. Flanigan R.C. de Kernion J.B. Ratliff T.L. Kavoussi L.R. Dalkin B.L. Waters W.B. MacFarlane M.T. Southwick P.C. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: receiver operating characteristics curves. J. Urol. 152 1994 2037
7. Bazinet M. Meshref A.W. Trudel C. Aronson S. Peloquin F. Nachabe M. Begin L.R. Elhilali M.M. Prospective evaluation of prostate specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 43 1994 44
8. Meshref A.W. Bazinet M. Trudel C. Aronson S. Peloquin F. Nachabe M. Dessurealut J. Aprikian A.G. Begin L.R. Elhilali M.M. Role of prostatic-specific antigen density after applying age-specific prostate-specific antigen reference ranges. Urology 45 1995 972
9. Catalona W.J. Smith D.S. Wolfert R.L. Wang T.J. Rittenhouse H.G. Ratliff T.L. Nadler R.B. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. J.A.M.A. 274 1995 1214
10. Woodrum D. French C. Shamel L.B. Roman S. Stability of free PSA in serum J. Urol., part 2 155 1996 421A abstract 442
11. Smith D.S. Catalona W.J. Keetch D.W. Comparison of percent free PSA and PSA density as methods to enhance the specificity of PSA screening J. Urol., part 2 155 1996 422A abstract 445
12. Oesterling J.E. Wojno K.J. England B. Vessella R.L. Lange P.H. Noteboon J. Wright G.L. Jr. Schellhammer P.F. Weigand R.A. Olson R.M. Dowell B.L. A comparison of free to total PSA (F/T) ratio to total PSA for distinguishing benign prostatic hyperplasia (BPH) from prostate cancer (Ca) using the Abbott AxSYM system J. Urol., part 2 155 1996 370A abstract 240